Goodman Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Goodman Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70	Closed	-$34.4K	–	165
2026 Q1	$34.4K	Sell	70 -260	-79%	-$141K	0.01%	121
2025 Q4	$191K	Hold	330	–	–	0.05%	71
2025 Q3	$160K	Hold	330	–	–	0.04%	74
2025 Q2	$134K	Hold	330	–	–	0.05%	66
2025 Q1	$164K	Buy	+330	New	+$179K	0.05%	79
2024 Q4	–	Sell	-338	Closed	-$209K	–	168
2024 Q3	$209K	Sell	338 -127	-27%	-$75.2K	0.06%	82
2024 Q2	$257K	Buy	465 +135	+41%	+$77.3K	0.08%	76
2024 Q1	$192K	Hold	330	–	–	0.06%	73
2023 Q4	$175K	Hold	330	–	–	0.06%	71
2023 Q3	$167K	Sell	330 -21	-6%	-$11.2K	0.06%	71
2023 Q2	$183K	Hold	351	–	–	0.07%	60
2023 Q1	$202K	Sell	351 -17	-5%	-$9.58K	0.11%	47
2022 Q4	$203K	Sell	368 -20	-5%	-$10.6K	0.12%	45
2022 Q3	$197K	Sell	388 -54	-12%	-$30.2K	0.11%	48
2022 Q2	$240K	Hold	442	–	–	0.11%	42
2022 Q1	$261K	Buy	442 +142	+47%	+$81.6K	0.09%	58
2021 Q4	$200K	Buy	+300	New	+$187K	0.07%	61

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goodman Advisory Group's TMO Position: Q2 2026 in Review

Goodman Advisory Group sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 70 shares — an estimated $34.4K sold.

Goodman Advisory Group first reported a position in TMO in Q4 2021 and held it in 17 quarters. The position peaked at $261K in Q1 2022. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Goodman Advisory Group reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Goodman Advisory Group sold 70 Thermo Fisher Scientific shares in Q2 2026, an estimated $34.4K.
Goodman Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 17 quarters.
Goodman Advisory Group's Thermo Fisher Scientific position peaked at $261K in Q1 2022.
2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.